Pallu Reddanna Selected Research

chebulagic acid

9/2011	Chebulagic acid synergizes the cytotoxicity of doxorubicin in human hepatocellular carcinoma through COX-2 dependant modulation of MDR-1.
3/2009	Chebulagic acid (CA) attenuates LPS-induced inflammation by suppressing NF-kappaB and MAPK activation in RAW 264.7 macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pallu Reddanna Research Topics

Disease

17	Inflammation (Inflammations) 10/2021 - 10/2006
15	Neoplasms (Cancer) 01/2022 - 11/2003
4	Edema (Dropsy) 11/2018 - 06/2009
4	Carcinogenesis 10/2016 - 08/2008
4	Hepatocellular Carcinoma (Hepatoma) 09/2011 - 07/2007
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2008 - 08/2004
3	Infections 07/2022 - 08/2010
3	Body Weight (Weight, Body) 01/2020 - 10/2006
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2012 - 01/2009
2	Virus Diseases (Viral Diseases) 07/2022 - 09/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2019 - 11/2009
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2013 - 01/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2012 - 04/2012
1	Colitis 10/2021
1	Drug-Related Side Effects and Adverse Reactions 09/2020
1	Skin Neoplasms (Skin Cancer) 09/2019
1	Leukemia 09/2019
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2016
1	Sepsis (Septicemia) 01/2016
1	Atherosclerosis 01/2016
1	Osteoarthritis 01/2015

Drug/Important Bio-Agent (IBA)

10	EnzymesIBA 01/2019 - 10/2006
5	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2021 - 03/2009
5	Pharmaceutical PreparationsIBA 01/2019 - 05/2004
5	CarrageenanIBA 11/2018 - 08/2008
4	AntioxidantsIBA 01/2019 - 08/2004
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2018 - 06/2002
4	Celecoxib (Celebrex)FDA Link 01/2018 - 06/2002
4	LipoxygenasesIBA 10/2016 - 11/2009
4	LipopolysaccharidesIBA 01/2016 - 10/2006
4	PhycocyaninIBA 12/2010 - 11/2003
4	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2009 - 06/2002
3	LeukotrienesIBA 10/2021 - 10/2016
3	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2021 - 10/2015
3	ProstaglandinsIBA 01/2021 - 01/2009
3	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 09/2019 - 07/2007
3	LipidsIBA 01/2019 - 03/2011
3	Arachidonic Acid (Vitamin F)IBA 10/2016 - 03/2009
3	EicosanoidsIBA 04/2015 - 03/2009
3	Proteins (Proteins, Gene)FDA Link 08/2010 - 08/2004
2	Antiviral Agents (Antivirals)IBA 07/2022 - 09/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2021 - 03/2009
2	CytokinesIBA 09/2019 - 04/2018
2	Interleukin-6 (Interleukin 6)IBA 09/2019 - 12/2011
2	Ethanol (Ethyl Alcohol)IBA 04/2018 - 05/2008
2	Protein Isoforms (Isoforms)IBA 01/2016 - 03/2009
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 07/2012 - 04/2012
2	chebulagic acidIBA 09/2011 - 03/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2011 - 07/2007
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2010 - 07/2007
1	Drug CarriersIBA 01/2022
1	Dextrans (Dextran)FDA Link 10/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2021
1	inerminIBA 09/2020
1	echinoisoflavanoneIBA 09/2020
1	Ribavirin (Virazole)FDA LinkGeneric 09/2020
1	FlavonoidsIBA 09/2020
1	13-hydroxy-9,11-octadecadienoic acidIBA 01/2020
1	LigandsIBA 01/2020
1	15- hydroperoxy- 5,8,11,13- eicosatetraenoic acidIBA 09/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2019
1	13-hydroperoxy-9,11-octadecadienoic acidIBA 09/2019
1	AutoantibodiesIBA 01/2019
1	Phospholipase A2 ReceptorsIBA 01/2019
1	Phospholipases A2 (Phospholipase A2)IBA 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	naphthaIBA 04/2018
1	Cyclooxygenase 1IBA 04/2018
1	ethyl acetateIBA 04/2018
1	AcidsIBA 01/2018
1	NanoconjugatesIBA 01/2018
1	LycopeneIBA 10/2016
1	baicaleinIBA 10/2016
1	ResveratrolIBA 10/2016
1	BerberineIBA 10/2016
1	Phospholipases (Phospholipase)IBA 10/2016
1	Masoprocol (Actinex)FDA Link 10/2016
1	fisetinIBA 10/2016
1	Ellagic AcidIBA 10/2016
1	GenisteinIBA 10/2016
1	gingerolIBA 10/2016
1	CurcuminIBA 10/2016
1	EugenolIBA 10/2016
1	Ursolic AcidIBA 10/2016
1	ApigeninIBA 10/2016
1	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2016
1	Lipoproteins (Lipoprotein)IBA 01/2016
1	Secretory Phospholipases A2IBA 01/2016
1	CG100649IBA 01/2015
1	Inflammation MediatorsIBA 01/2014
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2013
1	2-mercaptopurineIBA 07/2012
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2012
1	PyrophosphatasesIBA 04/2012
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 04/2012

Therapy/Procedure

2	Therapeutics 07/2022 - 10/2016
1	Quantum Dots (Quantum Dot) 01/2018
1	Ligation 01/2016
1	Punctures 01/2016